Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
4,127 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01625741 | Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy(HYDRIC) | terminated | Phase 2 | 6 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Sep 29, 2015 | clinicaltrials |
| NCT00105950 | Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer | completed | Phase 2 | 126 | GlaxoSmithKlineINDUSTRY |
| 8 |
| Sep 28, 2015 |
| clinicaltrials |
| NCT00791778 | Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer | completed | Phase 2 | 246 | BayerINDUSTRY | 14 | Sep 28, 2015 | clinicaltrials |
| NCT00317408 | Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma | unknown | N/A | 96 | European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin LymphomaOTHER | 12 | Sep 25, 2015 | clinicaltrials |
| NCT00373425 | A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors(RADIANT) | completed | Phase 3 | 1,252 | OSI PharmaceuticalsINDUSTRY | 19 | Sep 17, 2015 | clinicaltrials |
| NCT02053597 | TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen(TRIUMPH) | withdrawn | Phase 2 | 0 | Jules Bordet InstituteOTHER | 1 | Sep 17, 2015 | clinicaltrials |
| NCT00057564 | A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma | completed | Phase 3 | 470 | Celgene CorporationINDUSTRY | 16 | Sep 11, 2015 | clinicaltrials |
| NCT02545725 | Quality of Life in Colorectal (ex-)Cancer Patients, Based on the Belgian Cancer Registry.(QOLColorect) | completed | — | 1,220 | Elizabeth Van EyckenOTHER | 1 | Sep 10, 2015 | clinicaltrials |
| NCT00570713 | An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer | completed | Phase 2 | 155 | MorphotekINDUSTRY | 5 | Sep 9, 2015 | clinicaltrials |
| NCT00528567 | BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer | completed | Phase 3 | 2,591 | Hoffmann-La RocheINDUSTRY | 40 | Sep 4, 2015 | clinicaltrials |
| NCT01333735 | Impact on Cognitive Function and Quality of Life of Adjuvant Chemotherapy in Patients Aged Over 65 Years: Application to Breast Cancer or Colon(COG AGE) | completed | — | 114 | Centre Francois BaclesseOTHER | 2 | Sep 4, 2015 | clinicaltrials |
| NCT01797354 | Impact of a Group Intervention on Breast Cancer Patient's Adjustment and Emotion Regulation at the End of Treatment | completed | Phase 2 | 260 | Université Libre de BruxellesOTHER | 1 | Sep 4, 2015 | clinicaltrials |
| NCT00144755 | R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma | completed | Phase 3 | 600 | Lymphoma Study AssociationOTHER | 3 | Sep 2, 2015 | clinicaltrials |
| NCT00144807 | ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma | completed | Phase 2 | 128 | Lymphoma Study AssociationOTHER | 3 | Sep 2, 2015 | clinicaltrials |
| NCT02491892 | A Study of Pertuzumab in Participants With Metastatic Breast Cancer | completed | Phase 2 | 79 | Hoffmann-La RocheINDUSTRY | 8 | Aug 25, 2015 | clinicaltrials |
| NCT02309242 | Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective Study | unknown | N/A | 60 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Aug 21, 2015 | clinicaltrials |
| NCT01121406 | BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer | completed | Phase 2 | 110 | Boehringer IngelheimINDUSTRY | 5 | Aug 13, 2015 | clinicaltrials |
| NCT01014208 | Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma(ORCHARRD) | completed | Phase 3 | 447 | GlaxoSmithKlineINDUSTRY | 26 | Aug 7, 2015 | clinicaltrials |
| NCT00003636 | Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer | completed | Phase 3 | 704 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 15 | Aug 5, 2015 | clinicaltrials |
| NCT00700102 | A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer. | completed | Phase 3 | 820 | Hoffmann-La RocheINDUSTRY | 15 | Jul 30, 2015 | clinicaltrials |
| NCT02512263 | Assessment of Adherence and Efficiency of a Home-based Training Program on Muscular Strength, Endurance and Qol for Colon Cancer Patients | unknown | N/A | 50 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Jul 30, 2015 | clinicaltrials |
| NCT01305577 | Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat | completed | Phase 3 | 363 | Kythera BiopharmaceuticalsINDUSTRY | 5 | Jul 14, 2015 | clinicaltrials |
| NCT02495051 | Esophageal Atresia: Metaplasia, Barrett(Oesophagix) | completed | — | 120 | University Hospital, LilleOTHER | 4 | Jul 13, 2015 | clinicaltrials |
| NCT01478594 | A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy | completed | Phase 2 | 265 | AVEO Pharmaceuticals, Inc.INDUSTRY | 12 | Jul 8, 2015 | clinicaltrials |
| NCT01657747 | Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer(S53580) | completed | N/A | 350 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 2, 2015 | clinicaltrials |
| NCT00510068 | Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors(RADIANT-3) | completed | Phase 3 | 410 | Novartis PharmaceuticalsINDUSTRY | 18 | Jul 1, 2015 | clinicaltrials |
| NCT01686880 | Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver(TRYPHON) | terminated | Phase 2 | 10 | Jules Bordet InstituteOTHER | 1 | Jul 1, 2015 | clinicaltrials |
| NCT01103323 | Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy | completed | Phase 3 | 760 | BayerINDUSTRY | 19 | Jun 24, 2015 | clinicaltrials |
| NCT01294644 | Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat | completed | Phase 3 | 360 | Kythera BiopharmaceuticalsINDUSTRY | 6 | Jun 12, 2015 | clinicaltrials |
| NCT01421316 | Hair-sparing Whole Brain Radiotherapy | terminated | Phase 2 | 29 | University Hospital, GhentOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT01242748 | A Degarelix Trial in Patients With Prostate Cancer | terminated | Phase 3 | 288 | Ferring PharmaceuticalsINDUSTRY | 13 | Jun 3, 2015 | clinicaltrials |
| NCT01323790 | Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation | completed | Phase 3 | 700 | AstraZenecaINDUSTRY | 8 | Jun 2, 2015 | clinicaltrials |
| NCT01384292 | Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain | terminated | Phase 3 | 14 | AstraZenecaINDUSTRY | 14 | Jun 1, 2015 | clinicaltrials |
| NCT01240421 | An Open-Label, Multi-Center, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer Refractory | approved for marketing | — | — | Eisai Inc.INDUSTRY | 3 | May 22, 2015 | clinicaltrials |
| NCT00199160 | Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck Cancer | completed | Phase 2 | 60 | Jules Bordet InstituteOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT01497457 | Interest of Saline MR Peritoneography for Pre-operative Assessment of Rectal Cancer | completed | N/A | 17 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT00430781 | Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer | completed | Phase 2 | 228 | GlaxoSmithKlineINDUSTRY | 13 | May 8, 2015 | clinicaltrials |
| NCT00075270 | Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer | completed | Phase 3 | 580 | GlaxoSmithKlineINDUSTRY | 25 | May 6, 2015 | clinicaltrials |
| NCT00172042 | A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 437 | Novartis PharmaceuticalsINDUSTRY | 15 | May 4, 2015 | clinicaltrials |
| NCT00351858 | Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer(IV REXBC 02) | terminated | Phase 2 | 40 | Neovii BiotechINDUSTRY | 1 | May 1, 2015 | clinicaltrials |
| NCT02415725 | Early Detection of Lymphedema After Cancer Treatments | unknown | N/A | 120 | Centre Hospitalier Universitaire Saint PierreOTHER | 1 | Apr 14, 2015 | clinicaltrials |
| NCT00943007 | Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors(RACING) | completed | N/A | 14 | Maastricht University Medical CenterOTHER | 2 | Apr 10, 2015 | clinicaltrials |
| NCT01224990 | Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Gastro-intestinal Tumors(s51240) | unknown | N/A | 150 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT01242436 | Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis | completed | N/A | 50 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT01265979 | WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib | completed | — | 5 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT00215683 | An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer | completed | Phase 2 / Phase 3 | 137 | Ferring PharmaceuticalsINDUSTRY | 7 | Apr 1, 2015 | clinicaltrials |
| NCT00117598 | Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)(OPTIMAL) | completed | Phase 3 | 169 | PfizerINDUSTRY | 18 | Mar 30, 2015 | clinicaltrials |
| NCT00254891 | Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer | terminated | Phase 3 | 828 | PfizerINDUSTRY | 26 | Mar 30, 2015 | clinicaltrials |
| NCT00254904 | Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC | terminated | Phase 3 | 839 | PfizerINDUSTRY | 24 | Mar 30, 2015 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials